PRTG activates the cGMP/PKG signaling pathway downstream of gastric cancer cells in response to the induction of the epithelial-mesenchymal transition (EMT) transcription factor ZEB1, which has an important role in the progression of gastric cancer [58]. The gene discussed is ZEB1; the disease is gastric cancer.